SCF^FBXW7 regulates G2-M progression through control of CCNL1 ubiquitination

Area of Science:

• Molecular Biology
• Cancer Genetics
• Cell Cycle Regulation

Background:

• FBXW7 is a tumor suppressor gene regulating protein stability and cellular proliferation.
• Mutations in FBXW7 are common in human cancers.
• The SCF-FBXW7 E3 ligase complex targets specific proteins for degradation.

Purpose of the Study:

• To identify novel genetic interactions involving FBXW7 using genome-wide CRISPR screens.
• To investigate the role of CCNL1 as a substrate of the SCF-FBXW7 E3 ligase.
• To explore the therapeutic potential of targeting the CCNL1-CDK11 complex in FBXW7-mutated cancers.

Main Methods:

• Genome-wide CRISPR screening to identify synthetic lethal interactions.
• Biochemical assays to confirm CCNL1 as an SCF-FBXW7 substrate.
• Cell cycle analysis to assess the impact of FBXW7 mutations on mitosis.
• Drug sensitivity assays using a CDK11 inhibitor.

Main Results:

• A novel synthetic lethal interaction between FBXW7 and CCNL1 was discovered.
• CCNL1 was identified as a direct substrate of the SCF-FBXW7 E3 ligase.
• FBXW7 loss-of-function mutations impair CCNL1 accumulation, leading to shortened mitotic time.
• Cells with FBXW7 mutations exhibit hypersensitivity to CDK11 inhibitors.

Conclusions:

• The FBXW7-CCNL1 axis is crucial for maintaining proper cell cycle progression.
• Targeting the CCNL1-CDK11 complex represents a promising therapeutic strategy for FBXW7-mutated cancers.
• This study reveals a new genetic vulnerability exploitable in cancer treatment.